Patient-Centric Rare Disease Genome Maps Join The Web
For far too long, rare disease patients and their guardians have had to wait “forever” for genetic information to be returned back to them. All
For far too long, rare disease patients and their guardians have had to wait “forever” for genetic information to be returned back to them. All
One of October’s headlines in the field of genomics and genetics included the acquisition of BioDiscovery by Bionano Genomics. I spoke with
Just 20 years ago, some expected the human genome to hold all the answers. Instead, we accumulated an almost unlimited backlog of new questions – a
This partnership will expand on the information currently available to establish and improve advanced testing to accurately diagnose complex diseases
Sept. 30, 2021 For the use with SOPHiA DDM to match tumor genomic profiles with targeted therapies OncoDNA, a genomic and theranostic company
Latest Strategic Initiatives Solidify Genome Medical as Clear Digital Genetic Health Leader Financing Led by Casdin Capital with Participation from
Aug 18, 2021GRAIL will remain a separate and independent unit, pending ongoing regulatory and legal review SAN DIEGO, /PRNewswire/ — Illumina,
August 09, 2021 04:02 PM Eastern Daylight Time TEMPLE CITY, Calif.–(BUSINESS WIRE)–Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the
SAN MATEO, Calif., June 3, 2021 /PRNewswire/ — Helix, the leading population genomics and COVID-19 testing company, has closed on its Series C
PALO ALTO, Calif., June 1, 2021 /PRNewswire/ — Genoox, the world’s first community-driven genomic data platform, announced today that it has
Complementary technologies will transform data analysis and reporting capabilities for prenatal diagnostic testing May 3, 2021, 08:00 AM Eastern
Supporting BCP’s contribution to €6.5 million Finnish-led PRIVASA project BC Platforms (BCP), a global leader in healthcare data management,
AI-Driven Genomics Company Uses Investment to Fuel Commercial Expansion March 16, 2021 Ann Arbor, MI Genomenon announced that it has completed a
Partnership improves access to genetic counseling services when suspected hereditary cancer gene variant is identified through Foundation
New, qualitive report provides an in-depth analysis across the complex, multi-step clinical genomics data process, including genomic data generation